BioCryst Pharmaceuticals (NASDAQ:BCRX) has hired former Inspire Pharmaceuticals executive Tom Staab to become the drug developer’s new CFO. Staab starts with Durham, North Carolina-based BioCryst on July 1. Current BioCryst CFO Stuart Grant has agreed to extend his employment an additional month until then. Staab has been executive vice president, CFO and treasurer of Inspire […]
BioCryst Pharmaceuticals (NASDAQ:BCRX) got its hands on some big dollars in the first three months of 2011, securing $55 million from a federal contract for its experimental flu treatment peramivir and net proceeds of $23 million through a deal with a Japanese partner. But here’s a number that might have slipped under the radar — […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.